Answers are grounded in this paper and cite their sources.
Ovarian stimulation for ovarian induction and in vitro fertilization (IVF) is largely used worldwide by many infertile couples. There are many controversial issues about the long-term risk of infertility drugs related to chemical structure, dose and number of cycles that could be involved in the occurrence of cancer. This may be due to multiple modes of action, all of which can induce multiple ovulation and alter steroidogenesis. This paper is a narrative review based on the published cases on the association between fertility medication and gynecological cancer risk. Our objective was to discuss the medium- and long-term effects of hormonal stimulation in infertile patients diagnosed with malignancy years after. Ovarian cancer, breast cancer and endometrial cancer risks related to drugs for infertility are discussed. In conclusion, due to the unknown risks after IVF and ovarian stimulation, these patients must be monitored for a long-term period. National registries collecting data about the type of drugs used, the dose and the duration of treatment are of major importance.
No takes yet. Share an insight, caveat, or question.
Hetea et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: